Biomedical Tissues raises €500K for the marketing and commercialisation of its landmark product – Tisseos®

26 September 2017

Biomedical Tissues, Atlanpole Biotherapies member and a medtech company, completed a €0.5 million capital increase over the summer.

The funds were jointly raised from existing business angel investors ABAB (Atlantique Business Angel Booster) alongside new investors including Fonds PLP (Pays de la Loire Participations, a Regional Co-investment Fund), and business angel group LMSI (Le Mans Sarthe Investissements). This is the first time that three Pays de la Loire funds dedicated to helping local businesses have co-invested. Dentists throughout France also invested giving a huge seal of approval for Tisseos®.

The capital increase will enable Biomedical Tissues to expand the marketing, communication, and business development of its landmark product Tisseos® – a resorbable synthetic membrane for the dental implantology market. Unlike other membranes on the market made from pork, bovine or equine origins, Tisseos® is 100% synthetic and as such is suitable for ALL patients.

For more informations visit their website.